Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Oktober 2025

Genmab — Oktober 2025

Planlagt Fastgjort Låst Flyttet Genmab
427 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bikube
    wrote on sidst redigeret af
    #171

    Thanks for the story E L, it´s nearly unbelievale, but fantastic.

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #172

      Petosemtamab shows first colorectal promise https://www.oncologypipeline.com/apexonco/petosemtamab-shows-first-colorectal-promise

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #173

        teclistamab - Myeloma Drug Performs Well in Autoimmune Diseases https://www.medpagetoday.com/rheumatology/generalrheumatology/117966

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #174

          TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly
          improves progression-free survival and overall survival versus standard of care https://www.jnj.com/media-center/press-releases/tecvayli-plus-darzalex-faspro-combination-regimen-significantly-improves-progression-free-survival-and-overall-survival-versus-standard-of-care

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #175
            • At almost three years follow-up, the combination of TECVAYLI and DARZALEX FASPRO met the primary endpoint of progression-free survival (PFS) - Independent Data Monitoring Committee (IDMC) recommended unblinding the study based on statistically significant results
            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #176

              J&J claims a Tecvayli/Darzalex combo win https://www.oncologypipeline.com/apexonco/jj-claims-tecvaylidarzalex-combo-win

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #177

                Genmab-partner viser bedre overlevelsesmuligheder for kræftsyge i kombinationsstudie https://proinvestor.com/investornyt/1371488/genmab-partner-viser-bedre-overlevelsesmuligheder-for-kraeftsyge-i-kombinationsstudie

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bikube
                  wrote on sidst redigeret af
                  #178

                  Måske derfor de ikke ville købe "Superdara".

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    Elmer
                    wrote on sidst redigeret af
                    #179

                    Her en vurdering med hjælp fra copilot med info fra Proinvestor. Hvis Tecvayli/Darzalex bliver en ny SOC i relapsede/refraktære myelom-patienter, kan royalty-strømmen blive en vigtig vækstdriver for Genmab – især hvis Darzalex fortsætter sin blockbuster-status og Tecvayli bliver en fast del af regimet.

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #180

                      Aktiespararna ger köpråd för Genmab. "Aktien har stigit en del under hösten men med höjda prognoser och ett
                      lovande förvärv ser vi fortsatt potential. Rådet blir köp med riktkurs 2.500 danska kronor", skriver Aktiespararna.

                      1 Reply Last reply
                      0
                      • R Offline
                        R Offline
                        Raun
                        wrote on sidst redigeret af
                        #181

                        Det er voldsomt, så ustabil kursen har været den seneste tid

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #182

                          Det er nok snarere sektoren der er ustabil

                          1 Reply Last reply
                          0
                          • A Offline
                            A Offline
                            Aps_invest
                            wrote on sidst redigeret af
                            #183

                            Vel bare ligeså ustabil som resten af markedet p.t 🙂

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #184

                              Markedet svinger med Trumpeten. 😉

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #185

                                Aktier: Er det korrektionstid? https://proinvestor.com/boards/128988

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #186

                                  earlier Interview Jan van de Winkel: keynote speaker of the 2025 Utrecht Science Lecture. https://www.utrechtsciencepark.nl/en/about/view/stories-interviews/interview-jan-van-de-winkel-keynote-opening-utrecht-science-week-september-26

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #187

                                    One of the first ESMO sessions , Rinatabart mentioned https://x.com/omalirp/status/1979131841329197409/photo/1

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Raun
                                      wrote on sidst redigeret af
                                      #188

                                      Argh, jeg synes nu godt noka t Venmab er i en liga for sig. Når vi snakker om ustabil kurs.... men en flot comeback, og nu på vej ned igen...

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        KWC
                                        wrote on sidst redigeret af
                                        #189

                                        https://ir.genmab.com/news-releases/news-release-details/genmab-announces-new-data-demonstrating-investigational

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          KWC
                                          wrote on sidst redigeret af
                                          #190

                                          Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cance

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper